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Acoustic Neuroma or Vestibular Schwannoma 
• They are not technically neuromas
• Arise from the vestibular components of the nerve
Overview of Cerebellopontine Angle Masses
• 10% of intracranial tumors are found in the Cerebellopontine Angle (CPA)
• Roughly 80% are Vestibular Schwannomas (VS)
• Differential of CPA masses
• Meningiomas
• Epidermoids
• Schwanommas of other nerves
• Dermoid Tumors
• Arachnoid Cysts
• Lipomas
• Metastatic Tumors
• Vascular Tumors
Historical Perspective
• Acoustic Neuromas were first described in the late 1700s
• Sandifort
• 1777 during an autopsy in a deaf patient
“documented a small body adherent to the right auditory nerve”
• In the mid 1800s an understanding that unilateral deafness, 
facial numbness, and progressive blindness from “optic 
neuritis” (papilledema) likely due to a CPA mass 
Historical Perspective
• Sir Charles Ballance
• 1894 first removal of VS, but patient died from complications
• 1907 first successful excision without patient mortality
• Overall high surgical mortality
• Horsley, von Eiselsberg, and Krause
• Largely performed unilateral suboccipital craniotomy with removal by finger 
dissection
• 1913 Presented data on 63 patients, 78% mortality
• Harvey Cushing
• 1917-1931 Developed bilateral suboccipital craniectomy for subtotal resection
• Described CPA syndrome
• Reduced mortality to 4%
• Critical of translabyrinthine approach
”If the otologist has ambitions to treat these lesions 
there is no possible route more dangerous or difficult”
Cushing 1917
Historical Perspective
• Walter Dandy
• 1916 Advocated for unilateral occipital flap with total tumor 
removal
• Decreased mortality to 10%, lower recurrence rate
• William House
• 1960s Resurrected translabyrinthine approach
• Pioneered use of operating microscope and surgical drill
• Also introduced middle cranial fossa approach
Relevant Anatomy
• Cerebellopontine Angle
• Located in Posterior Fossa
• Contains origin of many cranial nerves
• Medial Border: brainstem
• Lateral Border: petrous portion of temporal bone
• Superior Border: middle cerebellar peduncle
• Inferior Border: arachnoid of lower cranial nerves
• Anterior Border: Clivus
• Posterior Border: cerebellar tonsil
Epidemiology
• 80-90% of all CPA masses
• Incidence of 10 cases per million every year
• 2005 study suggested prevalence of incidental VS to be 2 in 
10,000 people
• Autopsy studies have detected higher rates indicating VS 
may not become clinically apparent
• 95% sporadic, 5% associated with neurofibromatosis type 2
• Presents in Adulthood: mean age 50 (31 for NF2)
Tumor Biology
• Arise from vestibular division of 8th cranial nerve
• Likely equal distribution between superior and inferior 
divisions
• Historically thought to originate from Obersteiner-Redlich 
zone
• Transitional area from central to peripheral myelin
• Now hypothesized to originate from Scarpa’s ganglion
• Highest concentration of schwann cells
Genetics
• Neurofibromatosis type 2
• Autosomal Dominant
• NF 2 gene at 22q12.2: tumor suppressor gene normally prevents 
cell proliferation
• Codes merlin protein
• Sporadic cases
• “Double Hit” hypothesis: 2 hits to normal genes
Antoni A Antoni B
Histology
Natural History
• Intracanalicular Phase
• Hearing loss tinnitus, vertigo
• Cisternal Phase
• Hearing loss, disequilibrium
• Compressive Phase
• Trigeminal symptoms, Headaches
• Hydrocephalic Phase
• 4th ventricle obstruction
• Clinical deterioration
• Facial weakness, vision loss
• Respiratory Failure and death
Common Findings Less Frequent Findings
• Unilateral/asymmetric hearing loss
• Up to 95%
• Tinnitus
• Up to 70%
• Disequilibrium 
• Up to 50%
• Greater than 70% with tumors >3cm 
• Facial Anesthesia
• Found in 50% in those with tumors 
>2cm
• Typically midface hypoesthesia
• Vertigo 
• Roughly 20% predominantly with 
smaller tumors
• Headache
• Mid sized 1-3cm tumors: 20%
• Tumors >3cm: approaching 40%
• Facial Spasm
• 10% typically orbicularis oculi
• Ophthalmic Manifestations
• Nystagmus and Papilledema
• Lower Cranial Neuropathies
• <3.5%
Symptoms
Signs
• Hitselberger’s Sign
• Sensory component of CN 7
• Nystagmus
• Trigeminal dysfunction
• Absent Corneal Reflex
• Temporal Wasting and Masseter 
Weakness
• Found rarely in advanced disease
• Cerebellar Signs
• Gait ataxia
• Poor finger to nose testing
Workup
• Audiologic Testing
• Pure Tone and Speech Audiometry
• Auditory Brainstem Responses
• Vestibular Testing
• Imaging
Audiometry
Hearing Loss
• Most common symptom
• Unilateral/Asymmetric
• 20% atypical pattern
• 5% present without hearing loss
• High frequencies typically affected
• Speech discrimination out of 
proportion to pure tone
• SSNHL
• Occurs in 20% of patients
• 1% of those with SSNHL will have a VS
Classification Systems
Hearing Loss Scheme SDS PTA
WRS
I 70-100
II 50-69
III 1-49
IV 0
AAO-HNS
A 70-100 0-30
B 50-69 31-50
C >50 50+
D <50 50+
Gardner-Robertson
I 70-100 0-30
II 50-69 31-50
III 5-49 51-90
IV 1-4 91+
V 0
• Used  in research to compare 
pre- and post-operative hearing
• Can aid in determining surgical 
approach
• AAO-HNS: Grade A and B 
considered serviceable hearing
• Gardner-Robertson: Grade 1 
and 2 considered serviceable 
hearing
Acoustic Reflexes
Hearing Loss
• Acoustic Reflex Decay
• Thresholds increased or absent if 
retrocochlear
Auditory Brainstem Responses
Hearing Loss
• Most common finding (40-60%) 
increased wave V latency
• Most specific finding only wave I 
present
• Pattern present in only 10-20% of 
cases
• Normal ABR in 10-15% of cases
• 33% of intracanalicular tumors
• High false positive rate >80%
Electronystagmography
Vestibular Testing
• Not very sensitive or specific for VS
• 70-90% will show an abnormality
• 50% of small tumors produce no abnormality
Imaging
• CT
• Non-contrast: Poor Sensitivity
• Contrasted: Ok for intracanalicular
tumors
• 90% of tumors enhance
• Can miss tumors <2cm
• MRI
• Gold standard
MRI Findings
Imaging
• Most Sensitive and Specific
• False negatives are rare
• Viral neuritis can produce false 
positives
• Sequences to obtain
• Pre- and post-contrast T1 images
• Fast spin echo T2 images
T1: mildly hypointense to brain, hyperintense to CSF
T1 Gd: contrast enhancement
MRI Findings
Imaging
• Most Sensitive and Specific
• False negatives are rare
• Viral neuritis can produce false 
positives
• Sequences to obtain
• Pre- and post-contrast T1 images
• Fast spin echo T2 images
T2: Fast Spine Echo
When to get an MRI?
Imaging
• MRI Triggers
• 15dB or greater asymmetry in 2 or more frequencies
• Discrimination asymmetry of 16% or greater
• Unilateral tinnitus
• Asymmetric SNHL + trigeminal symptoms
• Asymmetric SNHL + disequilibrium
• Goal of detection
• Small tumors have great surgical outcomes
• 98% cure, 99% intact facial nerve function, 80% preserved hearing
• Cost Analysis of ABR vs MRI: Study reviewed >300 cases of ASNHL
• ABR screening: $125,000, with 29% of tumors unidentified
• MRI screening: $156,000, with 0% lesions missed (at a cost of $99 more per case)
Reflexive MRI vs Serial Audiograms
Imaging
• VS is not the only cause of asymmetric SNHL
• Tumor growth is generally slow
• Cost analysis of serial audiograms comparing MRI early vs after progression
• Early MRI: $210,000
• After audiogram progression: $186,000
• May risk: 
• Delayed diagnosis
• Irreversible hearing loss 
• Inability to perform hearing preservative procedure
• Decision to obtain MRI should be based on global clinical picture
Meningioma Vestibular Schwannoma
• “Dural tail”
• Extend along petrous ridge
• Iso/hypointense on T1
• Hypo to hyperintense on T2
• Sessile appearance
• Ice cream cone appearance in IAC
• Bony erosion in IAC
• Globular appearance
• Can have cystic degeneration.
Imaging
Meningioma Vestibular Schwannoma
Imaging
Differential Diagnosis
• Epidermoids: 
• similar to cholesteatomas, from epithelial rest cells
• Hypointense T1 and bright on T2
• Arachnoid Cysts
• Treat with drainage
• Schwanommas of other nerves
• Cholesterol Granulomas 
• bright on T1 and T2
• Embryonic Tumors 
• excise when they cause dysfunction
• Hemangiomas 
• can form near geniculate producing progressive facial weakness
• Glomus Tumors
• Jugular Foramen Syndrome
Management Options
• Observation with Serial Imaging
• Stereotactic Radiation
• Microsurgery
Observation
Management
• Set Expectations
• 14-24% of patients being observed will go on to some form of treatment
• Average growth 2mm/year, but can range from 0 to 2cm annually
• Factors favoring observation
• Minimal symptoms
• Long standing stable history, may indicate slow growth rate
• Comorbid conditions and general health
• Refusing other treatment
• Protocol
• Follow up scan in 6 months, then serial imaging yearly
Stereotactic Radiosurgery
Management
• Introduced by Leskell in 1969
• Damages vascular endothelium
• Goal is to arrest tumor growth
• Gamma Knife uses multiple beams of ionizing radiation 
• LINAC uses a linear accelerator as its source of radiation
• Benefits
• Non-invasive
• Early return to function
• Avoids surgery
• Fractionated Radiotherapy
• Multiple sessions
Stereotactic Radiosurgery Outcomes
Management
• Transient increase in tumor size due to central necrosis in roughly 20%
• Gamma Knife study by Boari et al
• Tumor control in 97.1% 
• Tumor volume reduction in 82.7%, mean relative volume reduction 34.1%
• May require salvage surgery
• Increased trigeminal neuropathy
• Does not address disequilibrium
Surgery
Management
• Translabyrinthine Approach
•Middle Cranial Fossa Approach
• Retrosigmoid-Suboccipital Approach
Advantages Disadvantages
• Least cerebellar retraction
• Wide exposure of posterior fossa
• No size limitations for resection
• Easy identification of facial nerve
• Low recurrence rates
• Less headaches
• Sacrifices residual hearing
• Fat graft donor site morbidity
Management: Translabyrinthine
Translabyrinthine
Management
• Postauricular incision
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Translabyrinthine
Management
• Postauricular incision
• Mastoidectomy
• Dural Exposure
• Facial Nerve Identification
• Labyrinthectomy
• IAC Exposure
• Dura Incised
• Identify CN VIII components
• Tumor Debulking
• Tumor Dissected from Facial Nerve
• Fat graft, dural repair, and closure
Advantages Disadvantages
• Best hearing preservation
• Adequate exposure of lateral IAC, 
CPA , and clivus
• Extradural drilling
• Limited to smaller tumors <2cm
• Temporal lobe retraction
• Limited posterior fossa exposure
• Facial nerve dissection
Management: Middle Cranial Fossa
Middle Cranial Fossa
Management
• Temporal skin incision
• Temporal craniotomy
Middle Cranial Fossa
Management
• Temporal skin incision
• Temporal craniotomy
• Temporal lobe retraction
• Dural elevation
• Geniculate identified and exposed
• Labyrinthine portion followed to IAC
• IAC exposed
• Tumor debulking and dissection
• IAC packed
• Craniotomy repaired
• Wound closure
Advantages Disadvantages
• Wide exposure of brainstem and 
lower cranial nerves
• Can preserve hearing
• Can resect large tumors
• Posterior approach to facial nerve
• Cerebellar retraction
• Tumor must have <2cm IAC 
extension
Management: Retrosigmoid
Retrosigmoid
Management
• Post auricular Incision
• Suboccipital craniotomy
• Tumor debulking and dissection
• Dural and craniotomy closure
Management Considerations
• Factors
• Serviceable Hearing
• Tumor Size
• Tumor Position
• Anatomic Considerations
• Surgeon Preference
• Patient Preference
• Debulking vs Total Resection
Complications
• Vascular Injury
• Facial Nerve Paralysis
• CSF Leak
• Headache
• Meningitis 
• Tinnitus
• Balance Dysfunction
• Seizure, Hydrocephalus, and Stroke
• Mortality
Vascular Injury
Complications
• Arterial: AICA, labyrinthine artery, branches to facial nerve
• Venous: sigmoid sinus, petrosal vein of Dandy, vein of Labbé
• Can produce cerebral edema
• Posterior Fossa Hemorrhage
• Brainstem compression
• Rapid neurologic deterioration
• Potentially fatal
Facial Nerve Injury
Complications
• Preservation Rates (HB 1-2)
• Retrosigmoid: 91%
• Middle Cranial Fossa: 88%
• Translabyrinthine: 77%
• Delayed Onset (>72hrs post op)
• Occurs in 5% of cases
• 79% regain function after 1 year
CSF Leak
Complications
• Can occur early (POD 2-3) or late (POD 10-14)
• Highest in retrosig approach: 11%
• Translab has 8% rate
• Middle cranial fossa has 6%
• Treatment
• Conservative: bed rest, stool softeners, diuresis
• May require lumbar drain, shunting, or operative repair
Headache
Complications
• Post op headache of >3 months duration occurs in roughly 10% of all cases
• Retrosig: 21%
• Middle Cranial Fossa: 8%
• Translab: 3%
• Possible etiology
• Bone dust contamination producing aseptic meningitis
• Cranioplasty
• Dural scarring
• Migraines
Other Complications
Complications
• Bacterial Meningitis
• Staph aureus most common organism
• Standard presentation and treatment
• Balance Issues
• Transient typically resolves in 6-9 months
• Tinnitus
• 50% of patients with preop tinnitus have cessation of symptoms
• Seizure/Hydrocephalus/Stroke: rare <2% of cases
• Mortality: roughly 1%
Outcomes
• Recurrence Rates
• Overall < 5%
• Most occur after retrosig approach
• Suspect with headaches, facial numbness, lower cranial neuropathies
• Hearing Results
• Hearing preservation ranges from 30-80% depending on approach and patient selection
• Better pre op hearing predicts better post op hearing
• Larger tumors associated with lower rates of serviceable hearing
• Gamma Knife and surgical treatment have similar hearing preservation rates
Conclusion
• Vestibular Schwannomas are the most common CPA tumor
• Unilateral SNHL or tinnitus requires further evaluation
• MRI is the confirmatory study of choice
• Some patients with few symptoms and small tumors can be observed
• Radiosurgery is appropriate for tumors <3cm in size
• In the setting of unserviceable hearing translab approach is best
• For hearing preservation use middle cranial fossa or retrosigmoid approach
Questions?
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